PERCEPTIVE ADVISORS LLC 13D and 13G filings for Fusion Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-01-19 4:37 pm Purchase |
2024-01-09 | 13G | Fusion Pharmaceuticals Inc. FUSN |
PERCEPTIVE ADVISORS LLC | 4,737,194 6.500% |
4,737,194![]() (New Position) |
Filing |